Belimumab: a step forward in the treatment of systemic lupus erythematosus.

Depascale, Roberto; Gatto, Mariele; Zen, Margherita; Saccon, Francesca; Larosa, Maddalena; Zanatta, Elisabetta; Bindoli, Sara; Doria, Andrea; Iaccarino, Luca

Depascale, Roberto; Gatto, Mariele; Zen, Margherita; Saccon, Francesca; Larosa, Maddalena; Zanatta, Elisabetta; Bindoli, Sara; Doria, Andrea; Iaccarino, Luca.

Afiliación

Depascale R; Division of Rheumatology, University of Padova, Padova, Italy.
Gatto M; Division of Rheumatology, University of Padova, Padova, Italy.
Zen M; Division of Rheumatology, University of Padova, Padova, Italy.
Saccon F; Division of Rheumatology, University of Padova, Padova, Italy.
Larosa M; Division of Rheumatology, University of Padova, Padova, Italy.
Zanatta E; Division of Rheumatology, University of Padova, Padova, Italy.
Bindoli S; Division of Rheumatology, University of Padova, Padova, Italy.
Doria A; Division of Rheumatology, University of Padova, Padova, Italy.
Iaccarino L; Division of Rheumatology, University of Padova, Padova, Italy.

Expert Opin Biol Ther ; 21(5): 563-573, 2021 05.

Article en En | MEDLINE | ID: mdl-33630721

Asunto(s)

Productos Biológicos; Lupus Eritematoso Sistémico; Anticuerpos Monoclonales Humanizados/uso terapéutico; Linfocitos B; Humanos; Lupus Eritematoso Sistémico/tratamiento farmacológico

Palabras clave

B lymphocyte inhibition; belimumab; drug efficacy; systemic lupus erythematosus

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Productos Biológicos / Lupus Eritematoso Sistémico Tipo de estudio: Guideline Límite: Humans Idioma: En Revista: Expert Opin Biol Ther Asunto de la revista: BIOLOGIA / TERAPEUTICA Año: 2021 Tipo del documento: Article País de afiliación: Italia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google